| ID/Version |
|
||||||||||||||
|
Sequence description from provider |
RecName: Full=Follistatin {ECO:0000303|PubMed:7600958}; Short=FS;AltName: Full=Activin-binding protein {ECO:0000303|PubMed:7956942};Flags: Precursor; | ||||||||||||||
| Provider | SWISS-PROT | ||||||||||||||
| Sequence |
Polypeptide
344
aa
|
||||||||||||||
| Source | |||||||||||||||
| Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
| Sequence references in MGI |
J:17693
Albano RM, et al., Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain. Development. 1994 Apr;120(4):803-13
J:23925 Matzuk MM, et al., Multiple defects and perinatal death in mice deficient in follistatin [see comments]. Nature. 1995 Mar 23;374(6520):360-3 J:182827 Lee SJ, et al., Regulation of muscle mass by follistatin and activins. Mol Endocrinol. 2010 Oct;24(10):1998-2008 J:185267 Winbanks CE, et al., Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol. 2012 Jun 25;197(7):997-1008 J:306591 Davey JR, et al., Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass. JCI Insight. 2016 Apr 21;1(5):e85477 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/20/2026 MGI 6.24 |
|
|
|
||